Title : Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation.

Pub. Date : 2012 Mar 1

PMID : 22333588






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We recently envisioned that intervention strategies aimed at reversing the bioenergetic signature of cancer cells (e.g., the antidiabetic biguanide metformin) should correct oncogene (e.g., HER2)-driven MHC-I defects, thus preventing immune escape of oncogene transformants. Metformin erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 First, we explored how metformin treatment impacted mitochondrial biogenesis in cultured breast cancer cells overexpressing the membrane tyrosine kinase receptor HER2, the best-characterized downregulator of MHC-I. Metformin erb-b2 receptor tyrosine kinase 2 Homo sapiens